Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|June 1, 1976
The interaction between halofenate and propranololD H Huffman, D L Azarnoff, D W Shoeman, et al.Gastroenterology|July 1, 1975
Plasma levels and excretion of estrogens in urine in chronic lever diseaseP J Pentikäinen, L A Pentikäinen, D L Azarnoff, et al.The American Journal of the Medical Sciences|May 1, 1979
A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patientsC A Dujovne, D L Azarnoff, P Pentikainen, et al.The American Journal of the Medical Sciences|November 1, 1976
A two-year crossover therapeutic trial with halofenate and clofibrateC A Dujovne, D L Azarnoff, P Pentikainen, et al.Clinical Pharmacology and Therapeutics|March 1, 1976
One-year trials with halofenate, clofibrate, and placeboC A Dujovne, D L Azarnoff, D H Huffman, et al.Current Opinion in Lipidology|December 31, 1997
New lipid lowering drugs and new effects of old drugsC A DujovneThe American Journal of Cardiology|May 15, 1997
The clinical therapeutic implications of the Scandinavian Simvastatin Survival StudyC A DujovneClinical Cardiology|February 1, 1991
Drug intervention trials in dyslipidemia: the past and the futureC A DujovneClinical Pharmacokinetics|January 1, 1976
Drug protein binding and the nephrotic syndromeR Gugler, D L AzarnoffThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Diphenylhydantoin potency and plasma protein bindingD W Shoeman, D L AzarnoffPageof 12